Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

Eli Lilly HQ

Lilly to buy migraine drug developer CoLucid for $960m

Deal revolves around lasmiditan, which the firm out-licensed in 2005

- PMLiVE

Sobi looks to real-world trial to push Elocta take-up

Aims to show haemophilia A treatment’s benefit to reimbursement authorities

Patient-centred care innovation in dementia: a conversation with Neil Maiden

Content Marketing Manager Liz Inskip interviews Neil Maiden of City, University of London, about his work developing mobile technology solutions for residential dementia care, and what the challenges facing innovators...

Blue Latitude Health

Strategic symbionts

Strategic alliances are becoming more interesting and more important 

- PMLiVE

Tonic Life Communications expands leadership team

Appoints Stephanie DeViteri, Dana Lynch, Kelly Kutchinsky and Theresa Dolge

Sanofi reception

Sanofi wins EU approval for new diabetes combination Suliqua

European Commission licenses the once-daily version of Lantus and Lyxumia

AstraZeneca AZ

AZ tweaks immuno-oncology trials as it chases lung cancer leaders

Toughens targets for durvalumab in NSCLC monotherapy and combination study

UK flag

May says UK’s science base is a “negotiating priority” for Brexit

Stokes confidence in UK pharma as science and innovation featured among 12 key priorities

Market access in Europe: balancing access and affordability

European governments continue to pursue national agendas for market access, while also exploring opportunities to work together to achieve lower prices for new drugs

- PMLiVE

Targovax appoints chief financial officer

Dr Erik Digman Wiklund succeeds Oystein Soug

- PMLiVE

Dr Michael Mehler joins leon-nanodrugs as CEO

He succeeds Dr Ted Odlaug

Introduction to the manufacturing of biologics

The last decade has seen the rapid growth of biologics in the pharma market, making them a key sector to watch. With their growing popularity, it’s important to understand the...

Blue Latitude Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links